Advertisement

Premier Biomedical, Inc. Company Profile

02:27 EDT 19th May 2013 | BioPortfolio

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, specifically targeting the treatment of Alzheimer's Disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Blood Sepsis and Viremia, and Cancer. Premier has licensed the technology behind multiple provisional patents in the United States and a PCT Europe National Patent in the areas of Cancer, Sepsis, and Multiple Sclerosis. Founded in 2010, Premier is headquartered in Florida, with offices in Pennsylvania. The Company’s common stock trades on the Over The Counter Bulletin Board under the ticker symbol “BIEI.” www.premierbiomedicalinc.com


News Articles [ 523 Associated News Articles listed on BioPortfolio]

[Premier Biomedical] gets rights to retinitis pigmentosa IP

[Premier Biomedical Inc.] (treatments for debilitating medical conditions) has licensed exclusive rights from an undisclosed company to a provisional patent application for retinitis pigmentosa. The I...

Premier Biomedical, Inc. Developing Revolutionary Medical Cures

Premier Biomedical, Inc. (OTCBB: BIEI) announced that they have begun trading on the OTC-BB fully reporting index at “BIEI”. Premier Biomedical Inc’s principal technology is...

Premier Biomedical, Inc. Announces Next Phase of Laboratory Testing of its Anti-Cancer Therapy

ST. PETERSBURG, Fla., March 28, 2013 /PRNewswire/ -- Premier Biomedical, Inc. (OTC-BB: BIEI) (http://www.premierbiomedical.com/) today announced that it has advanced its pre-clinical testing of i...

Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Point of Care Creatinine

The Premier healthcare alliance today announced a new agreement for point of care creatinine has been awarded to Nova Biomedical Corporation of Waltham, Mass....

Premier Biomedical, Inc. Issues Laboratory Testing Update

PORT RICHEY, Fla., Sept. 28, 2012 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCBB:BIEI), a research-based company that intends to discover and develop medical treatments for humans, specifically...

TARGET CANCER: Premier Biomedical, Inc. and UTEP Proof of Concept Test Proves Successful, Accurate to Picogram Level

Premier Biomedical, Inc. (OTC-BB: BIEI) has announced the successful outcome of a Proof of Concept Test performed by the University of Texas at El Paso (UTEP). This experiment tar...

Premier Biomedical Successfully Advances Cancer Research

ST. PETERSBURG, Fla., Dec. 5, 2012 /PRNewswire/ -- Premier Biomedical, Inc. (OTC-BB: BIEI) today announced successful advances in its cancer-focused research.  Researchers successfully&...

Premier Biomedical Announces Potential Therapy for Currently Untreatable Neurofibromatosis

ST. PETERSBURG, Fla., Jan. 9, 2013 /PRNewswire/ -- Premier Biomedical, Inc. (OTC-BB: BIEI) today announced a proposed novel therapy for the treatment of the currently untreatable neurological con...

PubMed Articles [ 88 Associated PubMed Articles listed on BioPortfolio]

Response to Dr Egan's letter.

The long-term effect of premier pay for performance on patient outcomes.

Pay for performance has become a central strategy in the drive to improve health care. We assessed the long-term effect of the Medicare Premier Hospital Quality Incentive Demonstration (HQID) on patie...

Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model.

This study was conducted to evaluate the dose range of etoricoxib in acute pain using the postoperative dental pain model further.

Seasonal variation in vitamin D status in professional soccer players of the English Premier League.

The prevalence of seasonal variation in vitamin D status was examined in 20 FA Premier League soccer players residing at a latitude of 53°N. Serum 25-hydroxyvitamin D (25(OH)D) levels decreased (P <...

Premier awards call for entries.

Clinical Trials [ 41 Associated Clinical Trials listed on BioPortfolio]

Clinical Outcomes After Bowel Resection in Patients Receiving Alvimopan Versus Standard of Care in the Premier Perspective Database

Alvimopan is the first and currently the only FDA-approved therapy for acceleration of the time to upper and lower gastrointestinal (GI) recovery following partial large or small bowel res...

Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru

This study will evaluate the effectiveness of community-level behavioral and biomedical interventions, each alone and combined, in reducing sexual risk behavior and HIV/sexually transmitte...

Safety & Performance Study of Lumen Biomedical's FiberNet Distal Protection System for the Treatment of Renal Artery Stenosis

To evaluate the procedural safety and filter efficiency of the FiberNet® Embolic Protection System when used in conjunction with the Boston Scientific Express SD Stent System for primary...

Effects of Contingency Management for Methamphetamine Abstinence on Post-Exposure Prophylaxis for HIV in Men Who Have Sex With Men (MSM)

This study seeks to decrease methamphetamine use and concomitant high-risk sexual behaviors among methamphetamine-using men who have sex with men (MSM) by combining a biomedical interventi...

Pre-Exposure Prophylaxis in YMSM

This is an exploratory mixed-methods research study that compares an efficacious behavioral HIV-prevention intervention (3MV) alone to the behavioral HIV-prevention intervention combined w...

Companies [ 997 Associated Companies listed on BioPortfolio]

Premier Biomedical, Inc.

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, specifically targeting the treatment of Alzheimer's Diseas...

Biomedical Polymers, Inc

Biomedical Polymers, Inc. is a quality manufacturer of plastic consumables for research and medical diagnostic laboratories. Our products are designed and manufactured to the highest quality standards...

Quertle, LLC

Quertle is a biomedical search engine focused on delivering informative results to biomedical researchers using advanced linguistic technologies, along with an in-depth und...

Cambridge Biomedical, Inc.

Cambridge Biomedical is a contract research organization (CRO) and diagnostic laboratory providing bioanalytical support to the pharmaceutical, biotechnology, and medical d...

Premier Studios

Curious. Courageous. Caring. Premier Studios is a full-service marketing firm specializing in business growth marketing for cause and calling brands. Functioning as a nontraditional business partner,...

More Information about "Premier Biomedical, Inc." on BioPortfolio

We have published hundreds of Premier Biomedical, Inc. news stories on BioPortfolio along with dozens of Premier Biomedical, Inc. Clinical Trials and PubMed Articles about Premier Biomedical, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Premier Biomedical, Inc. Companies in our database. You can also find out about relevant Premier Biomedical, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement